Feasibility and time gain of implementing artificial intelligence-based delineation tools in daily magnetic resonance image-guided adaptive prostate cancer radiotherapy

在日常磁共振图像引导自适应前列腺癌放射治疗中实施基于人工智能的勾画工具的可行性及时间优势

阅读:1

Abstract

BACKGROUND AND PURPOSE: Daily magnetic resonance image (MRI)-guided radiotherapy plan adaptation requires time-consuming manual contour edits of targets and organs at risk in the online workflow. Recent advances in auto-segmentation promise to deliver high-quality delineations within a short time frame. However, the actual time benefit in a clinical setting is unknown. The current study investigated the feasibility and time gain of implementing online artificial intelligence (AI)-based delineations at a 1.5 T MRI-Linac. MATERIALS AND METHODS: Fifteen consecutive prostate cancer patients, treated to 60 Gy in 20 fractions at a 1.5 T MRI-Linac, were included in the study. The first 5 patients (Group 1) were treated using the standard contouring workflow for all fractions. The last 10 patients (Group 2) were treated with the standard workflow for fractions 1 up to 3 (Group 2 - Standard) and an AI-based workflow for the remaining fractions (Group 2 - AI). AI delineations were delivered using an in-house developed AI inference service and an in-house trained nnU-Net. RESULTS: The AI-based workflow reduced delineation time from 9.8 to 5.3 min. The variance in delineation time seemed to increase during the treatment course for Group 1, while the delineation time for the AI-based workflow was constant (Group 2 - AI). Fewer occurrences of readaptation due to target movement occurred with the AI-based workflow. CONCLUSION: Implementing an AI-based workflow at the 1.5 T MRI-Linac is feasible and reduces the delineation time. Lower variance in delineation duration supports a better ability to plan daily treatment schedules and avoids delays.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。